Evidence map›Paper›PMID 36175812›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2022

Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study.

Ariel Kenig, Yonatan Oster, Ronit Cohen-Poradosu, Klaris Reisenberg, Anat Wieder-Finesod, Mirit Hershman-Sarafov, Ilana Oren, Gabriel Weber, Ron Dagan, Gili Regev-Yochay and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Pneumococcal infective endocarditis in Brazil: a multicenter study on a severe condition.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Ariel Kenig *Department of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Yonatan Oster *Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Ronit Cohen-PoradosuInfectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Klaris ReisenbergInfectious Disease Unit, Soroka University Medical Center, Beer Sheva, Israel.
Anat Wieder-FinesodInfectious Disease Unit, Sheba Medical Center, Ramat Gan, Israel.
Mirit Hershman-SarafovBnai Zion Medical Center, Haifa, Israel.
Ilana OrenInfectious Disease Unit, Rambam Medical Center, Haifa, Israel.
Gabriel WeberInfectious Disease Unit, Carmel Medical Center, Haifa, Israel.
Ron DaganFaculty of Health Science, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Gili Regev-YochaySackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Jacob StrahilevitzFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. jstrahilevitz@hadassah.org.il.ORCID http://orcid.org/0000-0002-9192-7164
Hebrew University of Jerusalem · ILTel Aviv University · ILBen-Gurion University of the Negev · ILBnai Zion Medical Center · ILRambam Health Care Campus · ILSoroka Medical Center · ILTechnion – Israel Institute of Technology · ILTel Aviv Sourasky Medical Center · IL

Funding

Pfizer 0887Z1-4603
6 · The paper itself

Abstract

In order to characterize pneumococcal endovascular infection in the post-vaccination era, a retrospective nationwide study based on the Israeli Adult IPD database was conducted. Between 2010 and 2019, 0.6% (23 cases) of IPD cases were of endovascular type, occurring mainly in males (72.3%) with underlying medical conditions (78.2%). Additional pneumococcal source (10 patients) and concomitant infections were not uncommon. Penicillin and ceftriaxone susceptibility rates were 65.2% and 91.3%, respectively; 60.9% of the isolates were not covered by the pneumococcal conjugate vaccine. 21.7% of patients died during hospitalization. In conclusion, pneumococcal endovascular infections still carry significant morbidity and mortality.

Indexed as

CeftriaxonePneumococcal InfectionsAdultHumansInfantMalePenicillinsPneumococcal VaccinesRetrospective StudiesSerotypingVaccines, ConjugateCeftriaxonePenicillinsPneumococcal VaccinesVaccines, ConjugateEndovascular infectionsInfective endocarditisInvasive pneumococcal diseaseStreptococcus pneumoniae

Identifiers

PMID36175812
OpenAlexW4297988861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.